Program

 

 

23 August 2019

 1:00 PMRegistration and Welcome Coffee
 2:00 PM

Welcome and Opening
Jorge Santana, MD - University of Puerto Rico, Puerto Rico

  Session 1: Keynote Lectures
Chairs:  Jorge Santana & Pablo Tebas
 2:15 PM

Starting HAART in 2019: When and How
Pedro Cahn, MD, PhD - Fundación Huésped, Argentina

 2:35 PM

Global Challenges in Hepatitis B Treatment
Iván Antúnez-González, MD - Gastroenterology Society of Puerto Rico, Puerto Rico

 2:55 PM 

Hepatitis C Elimination: Is It Possible?
Andrea Cox, MD - Johns Hopkins School of Medicine, United States

 3:15 PM Discussion
 3:45 PM
Coffee Break
  Session 2: HIV-Related Session
Chairs: Mauro Schechter & Vivian Tamayo
 4:15 PM

Challenges with the Implementation of PrEP
Kenneth Mayer, MD - The Fenway Institute/Harvard Medical School, United States

 4:35 PM 

Tamayo, Vivian 2019

The Puerto Rican Experience - Discussion
Vivian Tamayo, PRCONCRA

 5:00 PM 

PrEP After Sexual Exposures
Mauro Schechter, MD, PhD - Federal University of Rio de Janeiro, Brazil

 5:20 PM

New ARVs/New Strategies
Pablo Tebas, MD - University of Pennsylvania, United States

 5:40 PM Discussion
 6:00 PMWelcome Reception and Poster Viewing
 7:00 PMNetworking Dinner
 

24 August 2019

  Session 3: Viral Hepatitis-Related
Chairs: Iván Antúnez-González & Pedro Cahn
 8:30 AM

Local Situation in Puerto Rico: Epidemiology and Treatment Options
Jorge Santana, MD - University of Puerto Rico, Puerto Rico

 9:00 AM

DDA's Paradigm in HCV Treatment
David Kershenobich Stalnikowitz, MD, Phd - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico

 9:30 AM

 

David Roth, MDHCV Treatment in Renal Impaired Patients
David Roth, MD, PhD - University of Miami Health System, United States

 10:00 AMDiscussion
 10:15 AMCoffee Break and Poster Viewing
 Oral Abstract Presentations
Chairs: Camila Gelpi-Acosta & Angeles Rodríguez
 10:45 AMAcceptability and Concerns Over the Use of PrEP in Puerto Rico
Malave-Rivera
 #1
 10:55 AMHurricane Maria’s Viral Impact: HIV Care Outcomes Among Substance Users in Puerto Rico Following Hurricane Maria
Hernández
 #2
 11:05 AMThe Role of The National HIV Behavioral Surveillance System in Puerto Rico
Rolón Colón
 #3
 11:15 AMAssociations Between Hepatitis C and Social Determinants of Health in a Sample of Injecting Drug Users Living with HIV in Puerto Rico
Maisonet Alejandro
 #4
 11:25 AMQ & A Session
  Session 4: ART in Vulnerable Populations
Chairs: Carlos Rodríguez-Díaz & Pablo Tebas
 11:35 AMGelpi-Acosta, Camila 2019Problematic Use of Drugs and HIV and Hepatitis Risks in Puerto Rico
Camila Gelpi-Acosta, PhD - LaGuardia Community College, USA
 12:05 AM

Treatment and Care with Vulnerable Populations
Amanda Castel, MD, MPH - George Washington University, USA

 12:35 PM

Clinical Case Presentation(s)
Carlos Rodríguez-Díaz, PhD - George Washington University, USA

 12:50 PMDiscussion 
 1:00 PMLunch
  Session 5: ART in Special Populations and Comorbidities
Chairs: David Kershenobich Stalnikowitz & Amanda Castel
 2:00 PM

Prevention and care strategies for the high risk population in Puerto Rico
Carlos Rodríguez-Díaz, PhD - George Washington University, USA

 2:30 PM

The Struggles of the Aging (Co-infected) Population
Iván Meléndez-Rivera, MD, FAAFP - Chief Medical Director - Centro Ararat, Inc

 3:00 PM

Hepatitis C Issues in Liver Transplantation
José Rivera-Acosta, MD - Hospital Auxilio Mútuo, Puerto Rico

 3:30 PMDiscussion
 3:45 PMCoffee Break
  Session 6: Future Challenges
Chairs: Jorge Santana and Mauro Schechter
 4:15 PM 

From Long-Acting Antivirals to Functional Cure
Pablo Tebas, MD - University of Pennsylvania, United States

 4:45 PM

HIV and Viral Hepatitis: Cascade of Care in Puerto Rico
Angeles Rodríguez, MD, MPH - Department of Health, Puerto Rico

 5:15 PM Round Table Discussion: Cascade of Care
 5:45 PM 

Closing Remarks
Jorge Santana, MD - University of Puerto Rico, Puerto Rico